The INFANTS Act of 2025 proposes to amend the Federal Food, Drug, and Cosmetic Act to tighten safety controls for infant and toddler foods, including infant formula. It creates a new framework for sampling, testing, and recordkeeping, elevates enforcement by linking noncompliance to adulteration penalties, and adds environmental monitoring requirements for Cronobacter and Salmonella in powdered infant formula.
The act also sets a staged timeline tied to FDA guidance and silica-limits on testing; it aims to improve traceability, transparency, and rapid action when contamination is detected.
At a Glance
What It Does
The bill adds a new sampling/testing regime for infant and toddler foods, requiring facilities to sample, test, and follow a written sampling plan for contaminants (lead, cadmium, mercury, arsenic, and others). It also requires quarterly testing and broad recordkeeping.
Who It Affects
Food facilities that manufacture infant and toddler foods (including infant formula), accredited laboratories, and FDA/Secretary personnel responsible for enforcement and data collection.
Why It Matters
The framework intends to close gaps in testing, ensure consistent data on contaminant levels, and enable faster recalls and corrective actions to protect infant health.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The INFANTS Act of 2025 would expand the Federal Food, Drug, and Cosmetic Act to ramp up safety controls for infant and toddler foods. It adds a dedicated 425 sampling/testing regime requiring facilities to collect representative samples of their final products and perform testing for lead, cadmium, mercury, arsenic, and other contaminants as regulated.
Facilities must develop and follow a written sampling plan that specifies how many samples to take, how large each sample is, and which testing methods will be used. FDA guidance on when to test specific contaminants would be issued within 18 months of enactment.
Testing would occur at least quarterly for infant and toddler foods in final package form and for other foods as the Secretary determines necessary to protect public health.
The bill also strengthens records: facilities must keep detailed testing records for at least two years or the product’s shelf-life, including descriptions of foods tested, sample counts, sampling plans, who collected and tested samples, and methods used. Laboratories conducting testing must use internationally accredited laboratories, and testing under this section is exempt from some existing lab accreditation requirements.
Records must be promptly available to the Secretary and translations supplied if records are in a language other than English. In addition, the bill makes noncompliance with Section 425 an adulteration violation, expanding enforcement.
Finally, the bill adds environmental monitoring requirements for powdered infant formula to verify sanitation and hygiene controls, with a 180-day delayed applicability, and requires retention and accessibility of those environmental records.”,
The Five Things You Need to Know
Defines infant and toddler food as food for children up to 24 months, including infant formula.
Implements Section 425: facilities must sample, test, and follow a written sampling plan for contaminants with quarterly testing.
Requires laboratory accreditation for testing and broad, two-year (or shelf-life) records retention.
Treats noncompliance with sampling/testing as adulteration under Section 402, increasing enforcement leverage.
Imposes environmental monitoring for Cronobacter and Salmonella in powdered infant formula, with a 180-day delayed start and specified recordkeeping.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title and purpose
Sec. 1 establishes the act’s formal citation as the INFANTS Act of 2025 and states the bill’s purpose: to amend the Federal Food, Drug, and Cosmetic Act to improve safety for infant and toddler foods.
Definition of infant and toddler food
Sec. 2 adds a definition: “infant and toddler food” means food intended for children up to 24 months, including infant formula, clarifying the scope of the new safety regime.
Contaminants in food—sampling and testing
Sec. 425 requires facilities to sample and test infant/toddler foods for contaminants, develop a written sampling plan, and use specified test methods. The Secretary must issue guidance within 18 months to assist plan development and determine testing timing for specific contaminants; testing occurs at least quarterly and covers infant/toddler foods in final form, plus other foods the Secretary designates.
Adulteration
Sec. 402 is amended to add subsection (j): a food article that fails to comply with Section 425 becomes adulterated, enabling enforcement under the FD&C Act’s adulteration provisions.
Records for inspections
Sec. 704 is amended to allow the Secretary to request and review records relating to the specimen activities in advance of, or in lieu of, inspections, with clear requirements for timely submission and translation where needed.
Mandatory recall authority
Sec. 423(a) is amended to broaden recall authority when infant/toddler foods bear or contain a contaminant rendering them adulterated, enabling swifter product removals.
Reporting positive test results for pathogens in infant formula
Sec. 412 is amended to require rapid notification (within 24 hours) and proper disposal of products when tests show environmental pathogens in infant formula, plus a 90-day FDA review process with documentation of corrective actions.
Environmental monitoring
Sec. 412(n) adds an environmental monitoring program for Cronobacter and Salmonella in powdered infant formula, detailing location, sampling numbers, timing, recordkeeping for at least two years, and Secretary access; a 180-day delayed applicability mirrors Section 425’s timeline and preserves agency oversight.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Parents and guardians of infants and toddlers, who gain safer products and faster responses to contamination.
- Infant and toddler food manufacturers that implement robust sampling, testing, and environmental controls, which can reduce recalls and liability by meeting clear standards.
- Regulators and public health agencies (FDA/Secretary) with better data and traceability to enforce safety and protect public health.
- Healthcare systems and pediatric care providers, who benefit from a lower risk of exposure to contaminated foods.
Who Bears the Cost
- Manufacturers of infant and toddler foods bear the costs of sampling, testing, recordkeeping, and possible facility upgrades to meet new standards.
- Laboratories and third-party testing providers must achieve and maintain international accreditation for compliance with the new regime.
- Small manufacturers may face disproportionate burdens from compliance timelines, sampling plan development, and documentation requirements.
- Retailers and supply chains may incur costs related to recalls, product withdrawals, and communication to consumers.
Key Issues
The Core Tension
The central tension is between rigorous, uniform safety controls for infant foods and the compliance burden on manufacturers, particularly smaller facilities, balanced against the need for timely, actionable public health data and rapid recalls when contaminants are detected.
The INFANTS Act introduces a robust safety regime that raises the bar for infant and toddler food testing and environmental monitoring. The most significant tensions are logistical and economic: the upfront costs of implementing sampling plans, conducting regular testing, and maintaining detailed records; the challenge of ensuring ample, accredited laboratory capacity; and the risk that 180-day delayed applicability could slow full enforcement and public health gains.
The act relies on FDA guidance to operationalize some provisions, which can create transitional uncertainty for facilities adjusting to the new requirements. Enforcement relies on adulteration penalties, creating a strong incentive to comply but also raising questions about the proportionality of penalties for smaller players.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.